OVER-THE-COUNTER HISTAMINE H-2-RECEPTOR ANTAGONISTS - HOW WILL THEY AFFECT THE TREATMENT OF ACID-RELATED DISEASES

被引：19

作者：

HOLT, S

机构：

[1] SETON HALL UNIV, DEPT MED, S ORANGE, NJ 07079 USA

[2] NEW JERSEY INST TECHNOL, DEPT BIOENGN, ROSELAND, NJ USA

来源：

DRUGS | 1994年 / 47卷 / 01期

关键词：

D O I：

10.2165/00003495-199447010-00001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1 / 11

页数：11

共 34 条

[1] ADVERSE REACTIONS TO H2-RECEPTOR ANTAGONISTS IN DENMARK BEFORE AND AFTER TRANSFER OF CIMETIDINE AND RANITIDINE TO OVER-THE-COUNTER STATUS [J].

ANDERSEN, M ;

SCHOU, JS .

PHARMACOLOGY & TOXICOLOGY, 1991, 69 (04) :253-258

[2] SAFETY IMPLICATIONS OF THE OVER-THE-COUNTER AVAILABILITY OF H-2-ANTAGONISTS [J].

ANDERSEN, M ;

SCHOU, JS .

DRUG SAFETY, 1993, 8 (03) :179-185

[3]

ANDERSEN M, 1991, UGESKRIFT LAEGER, V20, P1410

[4]

BELLOC J, 1993, 2 P UN EUR GASTR WEE, pA132

[5] THE LUGANO STATEMENTS ON CONTROLLED CLINICAL-TRIALS [J].

BLUM, AL ;

CHALMERS, TC ;

DEUTSCH, E ;

KOCHWESER, J ;

ROSEN, A ;

TYGSTRUP, N ;

ZENTGRAF, R .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1987, 15 (01) :2-22

[6]

BLUM AL, 1989, ADV DRUG THERAPY GAS, P75

[7]

BROWN D, 1989, AM J GASTROENTEROL, V84, P1141

[8]

COLINJONES DG, 1988, LANCET, V1, P576

[9]

Drea EJ, 1992, J PHARM PRACTICE, V5, P22, DOI 10.1177/089719009200500106

[10]

FRESTON JW, 1990, AM J GASTROENTEROL, V85, P241

← 1 2 3 4 →